Department of Chemicals and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10598, Berlin, Germany.
Arch Toxicol. 2016 Aug;90(8):1939-48. doi: 10.1007/s00204-015-1615-5. Epub 2015 Oct 16.
Regulatory crosstalk between the aryl hydrocarbon receptor (AHR) and oestrogen receptor α (ERα) is well established. Apart from the nuclear receptors ERα and ERβ, oestrogen signalling further involves an unrelated G protein-coupled receptor termed GPR30. In order to investigate potential regulatory crosstalk, this study investigated the influence of G-1 as one of the few GPR30-specific ligands on the AHR regulon in MCF-7 cells. As a well-characterised model system, these human mammary carcinoma cells co-express all three receptors (AHR, ERα and GPR30) and are thus ideally suited to study corresponding regulatory pathway interactions on transcript level. Indeed, treatment with micromolar concentrations of the GPR30-specific agonist G-1 resulted in up-regulation of AHR as well as the transcripts for cytochromes P450 1A1 and 1B1, two well-known targets of the AHR regulon. While this was partly attributable to G-1-mediated inhibition of tubulin assembly and subsequent cell cycle arrest in the G2/M phase, the effects nevertheless required functional AHR. However, G-1-induced up-regulation of CYP 1A1 was not mediated by GPR30, as G15 antagonist treatment as well as a knockdown of GPR30 and AHR failed to inhibit this effect.
芳基烃受体 (AHR) 和雌激素受体 α (ERα) 之间的调控串扰是众所周知的。除了核受体 ERα 和 ERβ 之外,雌激素信号还涉及一种不相关的 G 蛋白偶联受体,称为 GPR30。为了研究潜在的调控串扰,本研究调查了 G-1 作为少数 GPR30 特异性配体之一对 MCF-7 细胞中 AHR 调控子的影响。作为一个经过充分研究的模型系统,这些人乳腺癌细胞共同表达所有三种受体(AHR、ERα 和 GPR30),因此非常适合在转录水平上研究相应的调控途径相互作用。事实上,用微摩尔浓度的 GPR30 特异性激动剂 G-1 处理会导致 AHR 以及细胞色素 P450 1A1 和 1B1 的转录物上调,这两种都是 AHR 调控子的众所周知的靶标。虽然这部分归因于 G-1 介导的微管组装抑制和随后的细胞周期停滞在 G2/M 期,但这些作用仍然需要功能性 AHR。然而,G-1 诱导的 CYP1A1 上调不是由 GPR30 介导的,因为 G15 拮抗剂处理以及 GPR30 和 AHR 的敲低都不能抑制这种效应。